全文获取类型
收费全文 | 2378篇 |
免费 | 200篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 31篇 |
儿科学 | 39篇 |
妇产科学 | 29篇 |
基础医学 | 430篇 |
口腔科学 | 130篇 |
临床医学 | 223篇 |
内科学 | 499篇 |
皮肤病学 | 72篇 |
神经病学 | 103篇 |
特种医学 | 74篇 |
外科学 | 267篇 |
综合类 | 59篇 |
预防医学 | 151篇 |
眼科学 | 32篇 |
药学 | 221篇 |
中国医学 | 2篇 |
肿瘤学 | 228篇 |
出版年
2023年 | 21篇 |
2022年 | 19篇 |
2021年 | 26篇 |
2020年 | 32篇 |
2019年 | 33篇 |
2018年 | 48篇 |
2017年 | 42篇 |
2016年 | 47篇 |
2015年 | 45篇 |
2014年 | 54篇 |
2013年 | 95篇 |
2012年 | 90篇 |
2011年 | 111篇 |
2010年 | 68篇 |
2009年 | 75篇 |
2008年 | 90篇 |
2007年 | 101篇 |
2006年 | 81篇 |
2005年 | 98篇 |
2004年 | 71篇 |
2003年 | 95篇 |
2002年 | 75篇 |
2001年 | 78篇 |
2000年 | 81篇 |
1999年 | 72篇 |
1998年 | 43篇 |
1997年 | 54篇 |
1996年 | 33篇 |
1995年 | 32篇 |
1994年 | 24篇 |
1993年 | 21篇 |
1992年 | 48篇 |
1991年 | 54篇 |
1990年 | 35篇 |
1989年 | 52篇 |
1988年 | 63篇 |
1987年 | 51篇 |
1986年 | 42篇 |
1985年 | 36篇 |
1984年 | 33篇 |
1983年 | 39篇 |
1982年 | 34篇 |
1981年 | 18篇 |
1979年 | 15篇 |
1978年 | 22篇 |
1977年 | 20篇 |
1976年 | 22篇 |
1975年 | 22篇 |
1974年 | 20篇 |
1972年 | 14篇 |
排序方式: 共有2590条查询结果,搜索用时 15 毫秒
71.
72.
73.
74.
Marcell J Tjrnild Lisa Carlson Hanse Sren N Skov Karen B Poulsen Mona Sharghbin Leila L Benhassen Diana M Rpcke Sten L Nielsen J Michael Hasenkam 《Interactive Cardiovascular and Thoracic Surgery》2021,32(6):978
Open in a separate windowOBJECTIVESEntire mitral valve reconstruction with an extracellular matrix tube graft is a potential candidate to overcome the current limitations of mechanical and bioprosthetic valves. However, clinical data have raised concern with respect to patch failure. The aim of our study was to evaluate the impact of extracellular matrix mitral tube graft implantation on mitral annular and subvalvular regional dynamics in pigs.METHODSA modified tube graft design made of 2-ply extracellular matrix was used (CorMatrix®; Cardiovascular Inc., Alpharetta, GA, USA). The reconstructions were performed in an acute 80-kg porcine model (N = 8), where each pig acted as its own control. Haemodynamics were assessed with Mikro-Tip pressure catheters and mitral annular and subvalvular geometry and dynamics with sonomicrometry.RESULTSCatheter-based peak left atrial pressure and pressure difference across the mitral and aortic valves in the reconstructions were comparable to the values seen in the native mitral valves. Also comparable were maximum mitral annular area (755 ± 100 mm2), maximum septal-lateral distance (29.7 ± 1.7 mm), maximum commissure–commissure distance (35.0 ± 3.4 mm), end-systolic annular height-to-commissural width ratio (10.2 ± 1.0%) and end-diastolic interpapillary muscle distance (27.7 ± 3.3 mm). Systolic expansion of the mitral annulus was, however, observed after reconstruction.CONCLUSIONSThe reconstructed mitral valves were fully functional without regurgitation, obstruction or stenosis. The reconstructed mitral annular and subvalvular geometry and subvalvular dynamics were found in the same range to those in the native mitral valve. A regional annular ballooning effect occurred that might predispose to patch failure. However, the greatest risk was found at the papillary muscle attachments. 相似文献
75.
Dorte Schou Nrxe Aidan Flynn Christina Westmose Yde Olga
strup Finn Cilius Nielsen Jane SkjthRasmussen Jannick Brennum Petra Hamerlik Joachim Weischenfeldt Hans Skovgaard Poulsen Ulrik Lassen 《Molecular oncology》2022,16(1):206
Treatment of glioblastoma (GBM) remains a challenging task, with limited treatment options, none offering a cure. Immune therapy has proven effective across different cancers with remarkable response rates. Tumor mutational burden (TMB) is a marker of response, but technical and methodological differences in TMB estimates have made a proper assessment and comparison challenging. Here, we analyzed a prospective collection of paired samples from 35 patients with newly diagnosed GBM, all of whom were wild‐type (WT) for isocitrate dehydrogenase, before and after treatment with radiotherapy and temozolomide. Seven patients (20%) had O6‐methylguanine‐DNA methyltransferase‐methylated tumors. Six patients (17%) had two relapse surgeries, and tissue from all three surgeries was collected. We found that accurate evaluation of TMB was confounded by high variability in the cancer cell fraction of relapse samples. To ameliorate this, we developed a model to adjust for tumor purity based on the relative density distribution of variant allele frequencies in each primary–relapse pair. Additionally, we examined the mutation spectra of shared and private mutations. After tumor purity adjustment, we found TMB comparison reliable in tumors with tumor purity between 15% and 40%, resulting in 27/35 patients (77.1%). TMB remained unchanged from 0.65 mutations per megabase (Mb) to 0.67/Mb before and after treatment, respectively. Examination of the mutation spectra revealed a dominance of C > T transitions at CpG sites in both shared and relapse‐private mutations, consistent with cytosine deamination and the clock‐like mutational signature 1. We present and apply a cellularity correction approach that enables more accurate assessment of TMB in paired tumor samples. We did not find a significant increase in TMB after correcting for cancer cell fraction. Our study raises significant concerns when determining TMB. Although a small sample size, corrected TMB can have a clinical significance when stratifying patients to experimental treatment, for example, immune checkpoint therapy. 相似文献
76.
77.
78.
Double-blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in Type 2 diabetic patients. 总被引:5,自引:0,他引:5
AIMS: Elevated levels of urinary albumin excretion rate (AER) predict high risk for progressing to end-stage renal disease. In streptozotocin-induced diabetes, supplementation with vitamin C or E reduces albuminuria and glomerular hypertrophy. We tested the hypothesis that supplementation of both vitamin C and E in pharmacological doses lowers AER in Type 2 diabetic patients with persistent micro/macroalbuminuria. METHODS: Thirty Type 2 diabetic patients with AER 30-300 mg/24 h were included in a double-blind randomised, cross-over trial. Patients received vitamin C (1250 mg) and vitamin E (680 IU) per day or matching placebo for 4 weeks with a 3-week wash-out period between treatment periods in random order. RESULTS: Combined treatment with vitamin C and E reduced AER by 19% (95% CI 6-34%) (p = 0.04), geometric mean 197 mg/24 h (95% CI 114-341 mg/24 h) vs. 243 mg/24 h (146-404 mg/24 h). No changes were seen in serum creatinine, haemoglobin A1C or blood pressure. Fasting plasma concentrations of vitamin C and E increased in all patients during active treatment (mean vitamin C 79.4 micromol/L (SD 27.8) vs. 41.9 micromol/L (18.4) and vitamin E 47.0 micromol/L (19.8) vs. 29.5 micromol/L (15.3), P < 0.000001). Except for two patients that started additional blood pressure lowering treatment during the run-in period, no changes in medication, food and exercise habits or in the number of smokers occurred during the study. CONCLUSION: Short-term treatment with vitamin C and E in pharmacological doses lowers AER in Type 2 diabetic patients with micro/macroalbuminuria. Further long-term, large-scale studies of this albuminuria reducing treatment modality are warranted. 相似文献
79.
80.
A radiological study on intra‐ and extra‐cranial calcifications in adults with X‐linked hypophosphatemia and associations with other mineralizing enthesopathies and childhood medical treatment 下载免费PDF全文